SEC Form 4 · accession 0001623919-16-000043
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Gilreath
Officer — Chief Executive Officer · Director
Period of report
Mar 16, 2016
Accepted (ET)
Mar 16, 2016 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1,F2 | Mar 16, 2016 | P | 20,000 | $5.06 | A | 753,250 | D | |
| Common stock, par value $0.001 per share | holding | — | — | — | 3,200 | I | By Spouse | |
| Common stock, par value $0.001 per share | holding | — | — | — | 12,243 | I | By Entrust Georgia, LLC for the benefit of Mark G. Gilreath | |
| Common stock, par value $0.001 per share | holding | — | — | — | 74,755 | I | By Mark Gregory Gilreath Irrevocable Trust | |
| Common stock, par value $0.001 per share | holding | — | — | — | 1,818 | I | By Daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging, inclusively, from $4.93 to $5.25 on purchases reported for March 16, 2016. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- F2The total direct shares shown includes 247,839 time-vesting restricted stock award shares.